Sera Prognostics, Inc. Class A Common Stock (SERA) Stock Price

SERAStock

$2.18−8.40%52W

Market Cap$86.00M

P/E—

PEG Ratio—

Div yield—

Beta1.01

SERA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-27.08%

Price vs S&P 500 (4W)4.34%

VGM Score34.73

Book Value / Share (Quarterly)$1.73

P/TBV (Annual)1.53x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-33.06%

Cash Flow / Share (Quarterly)$-0.70

Price vs S&P 500 (YTD)-38.06%

Gross Margin (TTM)-191.23%

Net Profit Margin (TTM)-56385.96%

EPS (TTM)$-0.65

10-Day Avg Trading Volume0.02M

EPS Excl Extra (TTM)$-0.65

Revenue Growth (5Y)21.98%

EPS (Annual)$-0.67

ROI (Annual)-42.34%

Gross Margin (Annual)-102.47%

Net Profit Margin (5Y Avg)-30822.98%

Cash / Share (Quarterly)$1.21

Revenue Growth QoQ (YoY)-63.16%

ROA (Last FY)-31.32%

Revenue Growth TTM (YoY)-50.43%

EBITD / Share (TTM)$-0.72

ROE (5Y Avg)-46.55%

Operating Margin (TTM)-64235.09%

Cash Flow / Share (Annual)$-0.68

P/B Ratio1.16x

P/B Ratio (Quarterly)1.18x

Net Income / Employee (Annual)$-449,700

EV / Revenue (TTM)1307.61x

Net Interest Coverage (TTM)-57.35x

ROA (TTM)-30.95%

EPS Incl Extra (Annual)$-0.67

Current Ratio (Annual)1.69x

Quick Ratio (Quarterly)2.02x

3-Month Avg Trading Volume0.05M

52-Week Price Return-8.40%

Revenue / Employee (TTM)$800

Tangible BV / Share (Quarterly)$1.71

P/S Ratio (Annual)971.72x

Asset Turnover (Annual)0.00x

52-Week High$3.95

Operating Margin (5Y Avg)-33100.58%

EPS Excl Extra (Annual)$-0.67

CapEx CAGR (5Y)37.08%

26-Week Price Return-15.83%

Quick Ratio (Annual)1.62x

13-Week Price Return21.11%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)2.12x

Enterprise Value$74.53M

Revenue / Share Growth (5Y)11.20%

Asset Turnover (TTM)0.00x

Revenue / Employee (Annual)$1,100

Pretax Margin (Annual)-39417.28%

Cash / Share (Annual)$1.01

3-Month Return Std Dev72.40%

Gross Margin (5Y Avg)2.91%

Net Income / Employee (TTM)$-452,700

ROE (Last FY)-42.34%

Net Interest Coverage (Annual)-16.01x

EPS Basic Excl Extra (Annual)$-0.67

Receivables Turnover (TTM)3.17x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.65

Receivables Turnover (Annual)3.52x

ROI (TTM)-41.01%

P/S Ratio (TTM)1380.86x

Pretax Margin (5Y Avg)-30822.98%

Revenue / Share (Annual)$0.00

Tangible BV / Share (Annual)$1.91

Price vs S&P 500 (52W)-26.71%

Year-to-Date Return-26.10%

5-Day Price Return12.95%

EPS Normalized (Annual)$-0.67

ROA (5Y Avg)-35.29%

Net Profit Margin (Annual)-39417.28%

Month-to-Date Return6.86%

Cash Flow / Share (TTM)$-1.20

EBITD / Share (Annual)$-0.75

Operating Margin (Annual)-45066.67%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-46.30%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.65

P/TBV (Quarterly)1.19x

P/B Ratio (Annual)1.51x

Pretax Margin (TTM)-56385.96%

Book Value / Share (Annual)$1.94

Price vs S&P 500 (13W)18.32%

Beta1.01x

Revenue / Share (TTM)$0.00

ROE (TTM)-41.02%

52-Week Low$1.56

vGradeD

gGradeD

mGradeC

vgmGradeD

SERA Earnings Surprise History

Q2 25-0.16est. -0.24

Q3 25-0.16est. -0.21

Q4 25-0.16est. -0.19

Q1 26-0.17est. -0.17

Q2 26-0.18est. -0.16

SERA Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.33

4.30

Industry Peers — Health Services(30)

Symbol	Value Score	Growth Score	Momentum Score	Price
SERASera Prognostics, Inc. Class A Common Stock	D	D	C	$2.18
NTRANatera, Inc. Common Stock	F	A	A	$336.71
LHLabcorp Holdings Inc.	C	D	B	$337.68
DGXQuest Diagnostics Inc.	C	D	B	$244.51
GHGuardant Health, Inc. Common Stock	F	A	A	$164.92
CAICaris Life Sciences, Inc. Common Stock	F	A	B	$28.01
RDNTRadNet, Inc. Common Stock	D	C	C	$76.86
BLLNBillionToOne, Inc. Class A Common Stock	F	F	C	$100.08
CELCCelcuity Inc. Common Stock	—	—	D	$92.27
GRALGRAIL, Inc. Common Stock	D	A	B	$82.54
VCYTVeracyte, Inc.	D	A	C	$44.04
CDNACareDx, Inc.	D	B	A	$50.80
PSNLPersonalis, Inc. Common Stock	F	D	A	$17.25
FTREFortrea Holdings Inc. Common Stock	B	F	A	$18.27
FRNMFreenome, Inc. Common stock	—	F	A	$13.99
LMRILumexa Imaging Holdings, Inc. Common Stock	C	C	B	$12.07
CSTLCastle Biosciences, Inc. Common Stock	D	B	B	$35.00
FLGTFulgent Genetics, Inc. Common Stock	C	D	C	$19.95
YDESYD Bio Limited Ordinary Shares	—	—	D	$4.68
BDSXBiodesix, Inc. Common Stock	D	B	A	$28.07
XGNExagen Inc. Common Stock	D	B	B	$7.60
PCSCPerceptive Capital Solutions Corp Class A Ordinary Shares	—	F	B	$11.95
BNRBurning Rock Biotech Limited American Depositary Shares	B	F	D	$9.80
MDXHMDxHealth SA Ordinary Shares	B	B	F	$0.79
ADVBAdvanced Biomed Inc. Common Stock	A	—	B	$9.18
AMSAmerican Shared Hospital Services	A	C	D	$1.47
ACONAclarion, Inc. Common Stock	—	B	D	$2.49
BGLCBioNexus Gene Lab Corp Common stock	B	F	F	$1.55
ACONWAclarion, Inc. Warrant	—	—	D	$0.03
EXASExact Sciences Corp	F	B	B	$0.00
YDESWYD Bio Limited Warrants	—	—	D	$0.36

About Sera Prognostics, Inc. Class A Common Stock

Sera Prognostics develops blood-based diagnostic tests that predict individualized maternal health risks, including premature birth, preeclampsia, gestational diabetes, and stillbirth. Using proprietary proteomics and bioinformatics technology, the company commercializes biomarker tests and predictive analytics products to improve maternal and neonatal health outcomes.